Table 2.
Presence of F nucleatum in colorectal cancer tissue and CRC-specific survival.
| F nucleatum | cases (n) | events (n) | aHR (95% CI) | bHR (95% CI) |
|---|---|---|---|---|
| Negative | 1174 | 216 | 1.00 (reference) | 1.00 (reference) |
| Positive | 142 | 34 | 1.97 (1.35-2.86) | 1.68 (1.09-2.59) |
| p-value | 0.0004 | 0.018 |
HR = Hazard Ratio, CI = Confidence Interval
a
multivariable analysis adjusted for sex, age at diagnosis, tumor site, hypermutation status, tumor burden, mutations in POLE, TP53, and ERBB3, and MSI status
b
multivariable analysis adjusted for sex, age at diagnosis, tumor site, hypermutation status, tumor burden, mutations in POLE, TP53, and ERBB3, MSI status, and tumor stage